Track topics on Twitter Track topics that are important to you
The Scandinavian country of Sweden is home to a thriving biotechnology industry, one of the top 5 in Europe. Europe has become a global center for the industry, helped by €2 billion worth of fu...
Eligard® is a hormone compound for the treatment of advanced, hormone-dependent prostate cancer. The active ingredient (leuprolide acetate) significantly reduces the level of the male sex hormon...
AA amyloidosis affects approximately 35,000 - 50,000 individuals in the United States, Europe (Top 5 countries) and Japan. The disease occurs in a subset of patients with long-lasting inflammatory c...
At OncoDNA, our philosophy is to provide the most suitable test in terms of rapidity and cost. That’s why we follow a 3 tier approach to find tumour mutations which can respond to new cancer t...
Phoenix MarCom is a specialist marketing communications company, working with clients in the clean tech (including renewables, environmental technology, low carbon and sustainability), scientific an...
The US FDA has banned products from a third Indian manufacturing plant operated by Wockhardt.
Mumbai-based pharmaceutical and biotechnology firm Wockhardt has been hit with more manufacturing woes as the FDA issued a warning letter against the company concerning the processes at its facility i...
Wockhardt, a Rs. 4,450 crore plus pharma major, has suffered heavy setback during the first quarter ended June 2016 and its consolidated net profit declined sharply by 82.7 per cent to Rs. 15.89 crore...
Global pharmaceutical and biotechnology company Wockhardt has chosen the latest version of Broughton Software’s LabHQ LIMS for its new quality control laboratories in Wrexham. This intuitive sof...
Wockhardt has said it will build a sterile manufacturing and drug testing facility at its site in Wrexham, Wales.
Efforts by Wockhardt to fix violations at drug plant in Wrexham, Wales are inadequate according to the US FDA which detailed its concerns in a warning letter this week.
Legal proceedings around Novartis' Galvus patent in India appear to have taken an interesting turn, with generic challenger Wockhardt indicating...
Cempra has asked Uquifa for API manufacturing data to support its US solithromycin efforts after raising concerns that information from Wockhardt in the current dossier will delay review.
To examine time-dependent predictors of functional impairment in older adults in Europe longitudinally.
Modern humans arrived in Europe ~45,000 years ago, but little is known about their genetic composition before the start of farming ~8,500 years ago. Here we analyse genome-wide data from 51 Eurasians ...
In Europe, the zoonotic parasite Dirofilaria repens continues to spread northward. We describe three likely autochthonous canine microfilaremic D. repens infections from Estonia, an European Union cou...
Corrigendum to "EuReCa ONE-27 Nations, ONE Europe, ONE Registry A prospective one month analysis of out-of-hospital cardiac arrest outcomes in 27 countries in Europe" Resuscitation 105 (2016) 188-195.